News

IBEM-IS has passed the 1,900 participant mark!
As of January 11, 2016, 1,949 participants representing 41 conditions have data entered into the IBEM-IS. Of those 1,949 participants, 1,364 were identified by NBS. Hyperphe/PKU has the largest number of enrollees (465) closely followed by MCAD (351), Biotinidase (208) and Galactosemia (189). Four other conditions have data for more than 50 participants: VLCAD (90), SCAD (66), PROP (60) and MSUD (56).